Integrated solution to purification challenges in the manufacture of a soluble recombinant protein inE. coli-Reference-Cited by-同舟云学术

Integrated solution to purification challenges in the manufacture of a soluble recombinant protein inE. coli

Published:2010-02-01 Issue:2 Volume:105 Page:239-249
ISSN:0006-3592
Container-title:Biotechnology and Bioengineering
language:en
Short-container-title:Biotechnol. Bioeng.

Author:

Caparon Maire H.,Rust Kevin J.,Hunter Alan K.,McLaughlin Joseph K.,Thomas Kristen E.,Herberg John T.,Shell Robert E.,Lanter Paul B.,Bishop Bruce F.,Dufield Robert L.,Wang Xing,Ho Sa V.

Publisher

Wiley

Subject

Applied Microbiology and Biotechnology,Bioengineering,Biotechnology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/bit.22542/fullpdf

Reference24 articles.

1. The dipeptide permease of Escherichia coli closely resembles other bacterial transport systems and shows growth-phase-dependent expression;Abouhamad;Mol Microbiol,1994

2. Peptide transport and chemotaxis in Escherichia coli and Salmonella typhimurium: Characterization of the dipeptide permease (Dpp) and the dipeptide-binding protein;Abouhamad;Mol Microbiol,1991

3. Molecular characterization of native and recombinant apolipoprotein A-I Milano dimer;Calabresi;J Biol Chem,1994

4. coliBASE: An online database for Escherichia coli, Shigella and Salmonella comparative genomics;Chaudhuri;Nucleic Acids Res,2004

5. The binding specificity of OppA determines the selectivity of the oligopeptide ATP-binding cassette transporter;Doeven;J Biol Chem,2004

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanodiscs: Game changer nano-therapeutics and structural biology tools;Nano Today;2023-12

2. Engineered Bacteria: General Overview as Therapeutic Agent and a Novel Drug Delivery System;Current Pharmaceutical Biotechnology;2023-09

3. Development of activated endothelial targeted high-density lipoprotein nanoparticles;Frontiers in Pharmacology;2022-08-29

4. Nanoengineering Apolipoprotein A1‐Based Immunotherapeutics;Advanced Therapeutics;2021-06-19

5. (r)HDL in theranostics: how do we apply HDL's biology for precision medicine in atherosclerosis management?;Biomaterials Science;2021